Preferred Name |
levobunolol |
|
Synonyms |
levobunololum 5-[(2S)-3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydronaphthalen-1(2H)-one C17H25NO3 5-[(2S)-3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalen-1-one Levobunolol (S)-5-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone |
|
ID |
http://purl.obolibrary.org/obo/CHEBI_6438 |
|
AHFScode |
52:92.00 |
|
ATCCode |
S01ED03 |
|
blocks | ||
CASRN |
47141-42-4 |
|
DBBrand |
akbeta betagan |
|
DBname |
levobunolol |
|
DBSynonym |
levobunolol hcl levobunololum [inn-latin] |
|
Definition |
A cyclic ketone that is 3,4-dihydronaphthalen-1-one substituted at position 5 by a 3-(tert-butylamino)-2-hydroxypropoxy group (the S-enantiomer). A non-selective beta-adrenergic antagonist used (as its hydrochloride salt) for treatment of glaucoma. |
|
has effect |
http://purl.obolibrary.org/obo/OAE_0000388 http://purl.obolibrary.org/obo/OAE_0000377 http://purl.obolibrary.org/obo/OAE_0000218 http://purl.obolibrary.org/obo/OAE_0000376 http://purl.obolibrary.org/obo/OAE_0000335 http://purl.obolibrary.org/obo/OAE_0000198 http://purl.obolibrary.org/obo/OAE_0000406 http://purl.obolibrary.org/obo/OAE_0000921 http://purl.obolibrary.org/obo/OAE_0000415 http://purl.obolibrary.org/obo/OAE_0000373 http://purl.obolibrary.org/obo/OAE_0000660 http://purl.obolibrary.org/obo/OAE_0001370 http://purl.obolibrary.org/obo/OAE_0000382 http://purl.obolibrary.org/obo/OAE_0000600 http://purl.obolibrary.org/obo/OAE_0000310 http://purl.obolibrary.org/obo/OAE_0000770 http://purl.obolibrary.org/obo/OAE_0001357 http://purl.obolibrary.org/obo/OAE_0000551 http://purl.obolibrary.org/obo/OAE_0000802 http://purl.obolibrary.org/obo/OAE_0001057 http://purl.obolibrary.org/obo/OAE_0000400 http://purl.obolibrary.org/obo/OAE_0000584 http://purl.obolibrary.org/obo/OAE_0000542 http://purl.obolibrary.org/obo/OAE_0000780 http://purl.obolibrary.org/obo/OAE_0000405 http://purl.obolibrary.org/obo/OAE_0000779 http://purl.obolibrary.org/obo/OAE_0000362 |
|
has pharmacological target | ||
has role | ||
InChI |
InChI=1S/C17H25NO3/c1-17(2,3)18-10-12(19)11-21-16-9-5-6-13-14(16)7-4-8-15(13)20/h5-6,9,12,18-19H,4,7-8,10-11H2,1-3H3/t12-/m0/s1 |
|
InChIKey |
InChIKey=IXHBTMCLRNMKHZ-LBPRGKRZSA-N |
|
label |
levobunolol |
|
may interact with | ||
prefixIRI |
obo2:CHEBI_6438 |
|
prefLabel |
levobunolol |
|
SMILES |
CC(C)(C)NC[C@H](O)COC1=CC=CC2=C1CCCC2=O CC(C)(C)NC[C@H](O)COc1cccc2C(=O)CCCc12 |
|
Synonym |
levobunololum 5-[(2S)-3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydronaphthalen-1(2H)-one C17H25NO3 5-[(2S)-3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalen-1-one Levobunolol (S)-5-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-1(2H)-naphthalenone |
|
xref |
Wikipedia:http://en.wikipedia.org/wiki/Levobunolol Drugs.com:http://www.drugs.com/cdi/levobunolol-drops.html CiteXplore:3067745 CiteXplore:19626454 KEGG COMPOUND:C07914 Drugs Product Database (DPD):2241575 Wikipedia:Levobunolol CASRN:47141-42-4 Patent:WO2011140194 CiteXplore:2881799 CiteXplore:23390358 Patent:US2011275617 CiteXplore:3019819 National Drug Code Directory:0023-4526-10 Beilstein:6484587 DrugBank:DB01210 CiteXplore:21368570 CiteXplore:3050679 KEGG DRUG:D08115 Patent:WO2008002929 CiteXplore:3513594 CiteXplore:3058836 Reaxys:6484587 PubChem Compound:39468 CiteXplore:3062528 PubChem Substance:46507518 CiteXplore:20960417 ChemSpider:36089 PharmGKB:PA164747027 ChEBI:6438 ChEMBL:775188 RxList:http://www.rxlist.com/cgi/generic/levobunolol.htm CiteXplore:3912600 Patent:US2011263638 CiteXplore:3881032 CiteXplore:2873545 HMDB:HMDB15341 |
|
subClassOf |